Momentum Biotechnologies Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Momentum Biotechnologies is a biotechnology research company based in Billerica, Massachusetts, that provides mass spectrometry–based drug discovery services to biopharma clients worldwide. As a drug discovery partner, it aims to accelerate programs by delivering rapid, high-quality data to identify and characterize leads across diverse target classes. The firm traces its roots to a team that developed the RapidFire high-throughput MS platform and has offered MS-enabled services since 2004, including work through PureHoney Technologies from 2015 to 2023. Its Billerica site houses a substantial mass spectrometry laboratory with more than 30 instruments and a fully equipped BL2 facility. In 2025 the company expanded through the acquisition of OmicScouts GmbH, a Munich-based proteomics CRO, which now operates as OmicScouts, a Momentum Biotechnologies Company. In May 2026 Momentum announced the launch of CHIPP technology to enable scalable and comprehensive target profiling.
1-888-653-2347 
support@leadiq.com 
